Brief: Getein Biotech Plans To Invest In Yestar Healthcare
April 8 (Reuters) - Getein Biotech Inc 603387.SS :
* SAYS IT SIGNS LETTER OF INTENT TO TAKE AT LEAST 30% STAKE
IN
YESTAR HEALTHCARE HOLDINGS CO LTD 2393.HK AND BECOME THE
LATTER'S CONTROLLING SHAREHOLDER
Source text http://static.sse.com.cn/disclosure/listedinfo/announcement/c/new/2022-04-09/603387_20220409_1_Bh8gBHMA.pdf
Further company coverage: 603387.SS
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))
Recent news on Yestar Healthcare Holdings
See all newsBrief: Yestar Healthcare Says Guangzhou Shengshiyuan Trading Shareholders Passed Resolution To Dissolve
Brief: Yestar Healthcare Expects FY2025 Net Loss Of Not Less Than RMB65 Million
Brief: Yestar Healthcare Says Exploring And Proposes To Invest In Advanced Materials Industry
Brief: Yestar Healthcare Considering JV With Genetron Health In Singapore, Indonesia & Malaysia
Brief: Yestar Healthcare Says Wang Chunlai Appointed As Executive Director